Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0000075252-21-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-11 | 2021-08-09+ | ACH | Pesicka Edward A | Pres, CEO, Dir | S - Sale | $38.34 | -152.3K | 1.46M | -9% | -$5.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | S | D | 28,276 | $38.11 | 1,384,189 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F7) Weighted average of the sale price range of $37.60 through $38.52. |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 31,978 | $38.16 | 1,352,211 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F8) Weighted average of the sale price range of $37.60 through $38.51. |
| 3 | Common | Common Stock | 2021-08-09 | S | D | 5,348 | $38.81 | 1,412,465 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F5) Weighted average of the sale price range of $38.80 through $38.85. (F6) Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. |
| 4 | Common | Common Stock | 2021-08-09 | S | D | 40,579 | $38.42 | 1,417,161 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F4) Weighted average of the sale price range of $37.80 through $38.80. |
| 5 | Common | Common Stock | 2021-08-09 | S | D | 3,840 | $38.83 | 1,457,740 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F3) Weighted average of the sale price range of $38.80 through $38.86. |
| 6 | Common | Common Stock | 2021-08-09 | S | D | 42,243 | $38.44 | 1,461,580 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F2) Weighted average of the sale price range of $37.80 through $38.80. |